Qiagen Balance Sheet Health
Financial Health criteria checks 6/6
Qiagen has a total shareholder equity of $3.5B and total debt of $2.0B, which brings its debt-to-equity ratio to 57%. Its total assets and total liabilities are $6.3B and $2.7B respectively. Qiagen's EBIT is $472.0M making its interest coverage ratio -17.5. It has cash and short-term investments of $1.5B.
Key information
57.0%
Debt to equity ratio
US$2.01b
Debt
| Interest coverage ratio | -17.5x |
| Cash | US$1.48b |
| Equity | US$3.53b |
| Total liabilities | US$2.74b |
| Total assets | US$6.27b |
Recent financial health updates
Qiagen (NYSE:QGEN) Seems To Use Debt Rather Sparingly
Dec 10
Here's Why Qiagen (NYSE:QGEN) Can Manage Its Debt Responsibly
Mar 20Recent updates
Qiagen (NYSE:QGEN) Seems To Use Debt Rather Sparingly
Dec 10Some Confidence Is Lacking In Qiagen N.V.'s (NYSE:QGEN) P/S
Oct 11An Intrinsic Calculation For Qiagen N.V. (NYSE:QGEN) Suggests It's 32% Undervalued
Sep 24With Qiagen N.V. (NYSE:QGEN) It Looks Like You'll Get What You Pay For
May 21Qiagen N.V. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next
May 03Here's Why Qiagen (NYSE:QGEN) Can Manage Its Debt Responsibly
Mar 20Calculating The Intrinsic Value Of Qiagen N.V. (NYSE:QGEN)
Feb 13Qiagen N.V.'s (NYSE:QGEN) Price Is Out Of Tune With Earnings
Jan 23Qiagen: No Upsides Slated In FY'23 In Core Business Lines, Reiterate Hold
Sep 09Qiagen: Major Asset Growth Needed In Post-Covid World
Jun 22Qiagen: Strong Q4, Derisked Portfolio, Fairly Valued
Feb 14Qiagen Non-GAAP EPS of $0.53, revenue of $498M, FY23 guidance initiated
Feb 07Qiagen, Helix partner to advance NGS companion diagnostics in hereditary diseases
Jan 06Qiagen's test gets FDA nod for companion diagnostic to Mirati's cancer drug Krazati
Dec 13Qiagen Non-GAAP EPS of $0.53 beats by $0.08, revenue of $500M beats by $17.91M
Nov 07Qiagen stock down after BHF downgrades rating to Neutral
Oct 10Financial Position Analysis
Short Term Liabilities: QGEN's short term assets ($2.5B) exceed its short term liabilities ($1.1B).
Long Term Liabilities: QGEN's short term assets ($2.5B) exceed its long term liabilities ($1.6B).
Debt to Equity History and Analysis
Debt Level: QGEN's net debt to equity ratio (15.1%) is considered satisfactory.
Reducing Debt: QGEN's debt to equity ratio has reduced from 71.4% to 57% over the past 5 years.
Debt Coverage: QGEN's debt is well covered by operating cash flow (31.5%).
Interest Coverage: QGEN earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:05 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Qiagen N.V. is covered by 63 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Owczarski | Avondale Partners |
| Catherine Ramsey Schulte | Baird |
| Carla Bänziger | Bank Vontobel AG |